While every sector of the economy has suffered, the slowdown has refocused attention on the life sciences, which venture capitalists had shunned only a few years ago. In biotechnology and biopharmaceuticals, venture capital investments are relatively safe with a strong potential for handsome returns. And more money means more jobs for scientists and researchers. "It's a sellers market," says Tom Abt, candidate resource manager for Bench International in Beverly Hills, California. "There is a lot going on in biotech. It's in the news everyday and any time the industry is talked about it creates a lot of action. I don't see it slowing down."
| Courtesy of Richard Carter |
 Richard Carter |
The job outlook for post-doctorate jobseekers may be a little less favorable, according to industry headhunters. That said, people with the right credentials, from the right academic laboratories, working in the right field--such as oncology or genomics--should have no problem ...
